Compare EVC & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVC | CLPT |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.0M | 353.5M |
| IPO Year | 2000 | 2009 |
| Metric | EVC | CLPT |
|---|---|---|
| Price | $8.76 | $13.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 3.6M | 633.1K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | ★ 5.35% | N/A |
| EPS Growth | ★ 47.59 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $536,034,000.00 | $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | $69.77 | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $1.95 | $8.27 |
| 52 Week High | $10.12 | $30.10 |
| Indicator | EVC | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 58.58 | 56.58 |
| Support Level | $2.70 | $12.87 |
| Resistance Level | $10.12 | $13.59 |
| Average True Range (ATR) | 0.73 | 0.95 |
| MACD | -0.19 | 0.14 |
| Stochastic Oscillator | 47.55 | 48.80 |
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.